Could a nasal spray soothe dry eyes?

NCT ID NCT05514041

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a nasal spray containing varenicline (OC-01) can improve tear film quality and reduce dryness in people with dry eye disease. Fifty adults used either the active spray or a placebo. Researchers measured tear film changes and symptom scores shortly after use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Varenicline nasal spray (OC-01)
What this could lead to
If it works, this could offer a new way to improve tear film quality and reduce dry eye discomfort quickly after use.
What could go wrong
This is a small, early-phase trial with only 50 participants. Results may not apply to everyone, and the effect may be short-lived or no better than placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Stephenson Eye Associates

    Venice, Florida, 34285, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.